Mayo Clinic cardiac surgeon, Simon Maltais, M.D., Ph.D., discusses how to prevent the revolution of LVAD therapy. For more information on left ventricular assist device or to request an appointment, Click Here.
As technology has improved, the size of the left ventricular assist device, or LVAD, has gotten smaller and the average survival rate has increased as well. Along with these advances, there are also risks. LVAD pumps can clot requiring the need for anticoagulation due to increased risk of stroke, renal infarct, or heart attacks. There are currently three approved LVAD pumps, so determining the correct pump for each patient can optimize device therapy and enhance outcomes.
Video Content Outline:
- Evolution of designs (1:42)
- Survival and expected outcomes (2:01)
- Continuous flow pump disease (2:25)
- Physiologic Impact (5:00)
- Clinical outcomes (6:34)
- Patients (7:44)
- Choosing the right pump (9:23)
- PREVENT trial and recommendations (11:00)
- Conclusion (14:26)